Skip to content
Parakho

Dr Reddys Laboratories Ltd

NSE DRREDDYBSE 500124drreddys.com

Q1 FY27, unaudited

Revenue
₹8,099.80 Cr
Profit after tax
₹435.60 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations8,099.80−5.51%33,700.20
Other income354.70+22.18%1,358.40
Total income8,454.50−4.60%35,058.60
Employee benefit expense1,651.60+9.85%5,990.90
Finance costs125.50+51.20%373.80
Depreciation & amortisation536.60+12.71%2,058.80
Total expenses7,902.00+13.57%29,679.30
Profit before tax552.50−70.99%5,379.30
Tax expense117.70−76.23%1,235.10
Profit after tax435.60−69.10%4,157.60
Total comprehensive income590.60−63.43%4,897.10
Earnings per share
Earnings per share, basic₹5.33₹50.41
Earnings per share, diluted₹5.33₹50.35

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Dr. Reddy's held a call to disclose that an impurity was found out of specification during testing of a scaled-up semaglutide API batch used to make the finished injectable formulation, prompting a halt to commercial supply pending investigation and revalidation. Management said no product already supplied to the market is affected, no regulatory filings are impacted, and the oral tablet formulation using a different API source is unaffected. The company said it expects to resume commercial supply around November, targeting 6 to 7 million pens between November and March against a prior annual target of 12 million pens.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 80 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.